Artist note
A sourced detail
Dr. Alan Ashworth is a world-renowned translational cancer biologist whose work has dramatically shaped modern cancer genetics and targeted therapy. From co-discovering the BRCA2 gene to pioneering the clinical use of PARP inhibitors, his research has advanced treatment options for BRCA1/2-related cancers. He has led top-tier institutions, including the Breakthrough Breast Cancer Research Centre and the Institute of Cancer Research (ICR), and he serves in leadership roles at UCSF, shaping cancer care and research on a national and international scale.